Inhibition of tumor growth and sensitization to chemotherapy by RNA interference targeting interleukin-6 in the androgen-independent human prostate cancer PC3 model

This publication has 39 references indexed in Scilit:

• Enhanced sensitivity to androgen withdrawal due to overexpression of interleukin-6 in androgen-dependent human prostate cancer LNCaP cells
  British Journal of Cancer, 2009
• From pathogenesis to prevention of castration resistant prostate cancer
  The Prostate, 2009
• Persistent Activation of Stat3 Signaling Induces Survivin Gene Expression and Confers Resistance to Apoptosis in Human Breast Cancer Cells
  Clinical Cancer Research, 2006
• Androgen Receptor Signaling
  Cancer Research, 2004
• Interleukin‐6: minor player or starring role in the development of hormone‐refractory prostate cancer?
  BJU International, 2003
• NF-κB in cancer: from innocent bystander to major culprit
  Nature Reviews Cancer, 2002
• Interleukin-6 Is an Autocrine Growth Factor in Human Prostate Cancer
  The American Journal of Pathology, 2001
• Interleukin-6- and Cyclic AMP-Mediated Signaling Potentiates Neuroendocrine Differentiation of LNCaP Prostate Tumor Cells
  Molecular and Cellular Biology, 2001
• Interleukin-6 Induces G1Arrest through Induction of p27Kip1, a Cyclin-Dependent Kinase Inhibitor, and Neuron-like Morphology in LNCaP Prostate Tumor Cells
  Biochemical and Biophysical Research Communications, 1999
• Two Signals Are Necessary for Cell Proliferation Induced by a Cytokine Receptor gp130: Involvement of STAT3 in Anti-Apoptosis
  Immunity, 1996